These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9814057)

  • 21. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary hormonal therapy for advanced prostate cancer.
    Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
    J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is overcoming hormone resistance in breast cancer possible?
    Orphanos G; Kakoullou N; Ardavanis A
    J BUON; 2008; 13(3):315-22. PubMed ID: 18979544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
    Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C
    Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers of drug resistance in relapsing colon cancer.
    Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antiproliferation in prostate cancer cell lines with cytostatics and combinations with resistance modifiers.
    Pintér O; Mucsi I; Molnár J
    In Vivo; 2005; 19(1):253-9. PubMed ID: 15796183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of hormone-relapsed prostate cancer.
    Parkinson RW; Austin RH; Parr NJ
    BJU Int; 2004 May; 93(7):1115. PubMed ID: 15142178
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular pharmacodynamics in childhood leukemia.
    Pieters R; den Boer ML
    Int J Hematol; 2003 Dec; 78(5):402-13. PubMed ID: 14704032
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.
    Sawicka M; Kalinowska M; Skierski J; Lewandowski W
    J Pharm Pharmacol; 2004 Sep; 56(9):1067-81. PubMed ID: 15324475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progression.
    Lamb DJ; Buttyan R
    J Urol; 2003 Apr; 169(4):1558. PubMed ID: 12629414
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for retinoblastoma.
    Chan HS; Gallie BL; Munier FL; Beck Popovic M
    Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient].
    Besse B; Soria JC
    Rev Prat; 2007 Feb; 57(4):429-40; quiz 440. PubMed ID: 17455746
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of extensive and metastasized cancers].
    Israël L
    Rev Prat; 1981 Oct; 31(43):3043-4 passim. PubMed ID: 7291909
    [No Abstract]   [Full Text] [Related]  

  • 36. The history of DNA reactive antitumour agents: is newer better?
    Gibson NW
    J Pharm Pharmacol; 1993 Apr; 45 Suppl 1():331-42. PubMed ID: 8098740
    [No Abstract]   [Full Text] [Related]  

  • 37. Classification of anticancer drugs--a new system based on therapeutic targets.
    Espinosa E; Zamora P; Feliu J; González Barón M
    Cancer Treat Rev; 2003 Dec; 29(6):515-23. PubMed ID: 14585261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current classification of chemotherapy used in the treatment of solid tumors].
    Bernard J; Boiron M; Jacquillat C; Weil M
    Bull Mem Soc Med Hop Paris; 1968; 119(2):127-32. PubMed ID: 5670362
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacodynamics of antineoplastic agents in vivo].
    Fujita H
    Kokubyo Gakkai Zasshi; 1971 Jun; 38(2):276. PubMed ID: 5288698
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental studies in local chemotherapy of mouth carcinomas].
    Schlegel D; Geyer S; Klemm J
    Fortschr Kiefer Gesichtschir; 1968; 13():39-44. PubMed ID: 5276892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.